We are funding research that is looking at using targeted radiotherapy in place of high dose chemotherapy when treating amyloidosis - a condition where the bone marrow makes abnormal plasma cells. Using a more targeted treatment may have less side effects than the chemotherapy.
Our researchers are also looking for new ways to treat people with Graft versus Host Disease who are no longer suitable for conventional steroid treatment, and are searching for ways to increase the effectiveness of stem cell or bone marrow transplants given from a brother or sister.
And we are supporting a trial that is optimising a treatment called donor lymphocyte infusion (DLI), which is when white blood cells that come from the stem cell transplant donor can be used after transplantation to prevent relapse.